B
MDCO

Bailard’s Medicines Co MDCO Stock Holding History

Bailard’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-26,000
Closed -$1K – 609
2019
Q4 		$1K Buy
+26,000
New +$1.73M ﹤0.01% 537

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bailard's MDCO Position: Q1 2020 in Review

Bailard sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 21,800 shares — an estimated $1.85M sold.

Bailard first reported a position in MDCO in Q2 2018 and held it in 7 quarters. The position peaked at $3.25M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Bailard reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Bailard sold 21,800 Medicines Co shares in Q1 2020, an estimated $1.85M.
  • Bailard first reported a position in Medicines Co in Q2 2018 and held it in 7 quarters.
  • Bailard's Medicines Co position peaked at $3.25M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Bailard's 13F filing for Q1 2020, filed 16 Apr 2020.